Optimizing the Dose of Glutamine Dipeptides and Antioxidants in Critically Ill Patients: A Phase I Dose‐Finding Study
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Supplementation with glutamine and antioxidants may be associated with an improvement in clinical outcomes, but the optimal dose of these substrates is unknown. The purpose of this study was to determine the safety of high doses of glutamine combined with antioxidants in critically ill patients. Methods: We conducted a single‐center, open‐label, dose‐escalating clinical trial. Mechanically ventilated adult patients with clinical evidence of hypoperfusion were sequentially enrolled to 1 of 5 groups. Group 1 (n = 30): no supplementation; group 2 (n = 7): 0.35 g/kg/d of glutamine IV; group 3 (n = 7): same as group 2 plus 15 g/d of glutamine and 150 μg of selenium enterally; group 4 (n = 7): same as group 2 plus 30 g/d of glutamine and 300 μg of selenium enterally; and group 5 (n = 7): same as group 4 plus an additional 500 μg of selenium IV. After enrollment, nutrients were started as soon as possible. All patients were fed enterally according to clinical practice guidelines. Results: The primary outcomes for this study were change in sequential organ function assessment (SOFA) score and safety parameters. Secondary outcomes included whole blood glutathione (GSH), thiobarbituric acid reactive substances (TBARS), and blood cells' mitochondrial DNA/nuclear DNA ratio (RATIO). There were no adverse events attributable to the study nutrients, and the maximum and Δ SOFA did not differ across groups. In group 2, a significant decrease in GSH levels was observed (p = .03). With subsequent groups, the slopes straighten out and the p values are no longer significant, suggesting a greater preservation of GSH levels with escalating doses. In group 2, the slope of the line representing TBARS was horizontal. With subsequent groups, the slopes decrease, and by group 5, this decrease reaches statistical significance (p = .03), suggesting a greater reduction in oxidative stress with the higher doses in group 5. The difference in slopes across all groups describing the mitochondrial RATIO is statistically significant (p = .001), again suggesting that, with higher doses, there is increased mitochondrial function. Conclusions: The doses of glutamine and antioxidants tested in this study seem to be safe and may have positive effects on some mechanistic endpoints. A larger trial will be necessary to confirm their therapeutic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients
Forceville, X., Vitoux, D., Gauzit, R., Combes, A., Lahilaire, P., & Chappuis, P. (1998) · Critical Care Medicine · doi:10.1097/00003246-199809000-00021 · Cited by 338
Cited by
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212722 · Cited by 904
Self-citationAndrews, P. J. D., Avenell, A., Noble, D. W., Campbell, M. K., Croal, B. L., Simpson, W. G., Vale, L. D., Battison, C. G., Jenkinson, D. J., Cook, J. A., et al. (2011) · BMJ · doi:10.1136/bmj.d1542 · Cited by 379
Beale, R. J., Sherry, T., Lei, K., Campbell-Stephen, L., McCook, J., Smith, J., Venetz, W., Alteheld, B., Stehle, P., & Schneider, H. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000297954.45251.a9 · Cited by 182
“com), intravenous or enteral administration of antioxidants was associated with a reduced mortality, and Heyland and colleagues (47) recently suggested that high doses of antioxidants may minimize mitochondrial damage in critically ill patients.”
BackgroundGrau, T., Bonet, A., Miñambres, E., Piñeiro, L., Irles, J. A., Robles, A., Acosta, J., Herrero, I., Palacios, V., Lopez, J., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820eb774 · Cited by 149
“There is at least one ongoing large trial that will examine the effect of different doses of glutamine on mortality as the primary end point (32).”
BackgroundHeyland, D. K., Elke, G., Cook, D., Berger, M. M., Wischmeyer, P. E., Albert, M., Muscedere, J., Jones, G., Day, A. G., & on behalf of the Canadian Critical Care Trials Group (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114529994 · Cited by 125
Self-citation
Metadata
- Authors
- Heyland, D. K., Dhaliwalm, R., Day, A., Drover, J., Cote, H., & Wischmeyer, P.
- Venue
- Journal of Parenteral and Enteral Nutrition
- Publisher
- Wiley
- Published
- 2007-03
- Volume
- 31
- Issue
- 2
- Pages
- 109-118
- ISSN
- 0148-6071 (ISSN-L)
- 1941-2444
- OpenAlex
- W2025141330
- Cited by
- 82
- References
- 2
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimizing the Dose of Glutamine Dipeptides and Antioxidants in Critically Ill Patients: A Phase I Dose‐Finding Study. https://app.cochat.ai/papers/10.1177/0148607107031002109
- The paper
- Heyland, D. K., Dhaliwalm, R., Day, A., Drover, J., Cote, H., & Wischmeyer, P. (2007). Optimizing the Dose of Glutamine Dipeptides and Antioxidants in Critically Ill Patients: A Phase I Dose‐Finding Study. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1177/0148607107031002109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.